Document Detail

Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience.
MedLine Citation:
PMID:  21069366     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: Cystosarcoma phylloides (CSP) is a fibro-epithelial neoplasm of the breast. Not all CSP cases present as malignant tumors; they are therefore classified as benign, malignant, and borderline subtypes according to the WHO classification. The classification is based on several histopathological features of the neoplasm, such as mitosis rate or invasive growth of the tumor. The progression of this disease is mainly influenced by the classification of their degree. In western countries, this tumor entity usually occurs between 50 and 60 years of age. The major problem in the handling of these patients is the high local recurrence rate, whereas haematogenous metastasis is seldom seen. We therefore report three cases of haematogenous spread in a group of eight patients (two borderline and six malignant cases of CSP).
MATERIALS AND METHODS: In this study, we investigated all patients suffering from malignant or borderline CSP, between May 1995 and January 2009, who were under the care of the Department of Gynecology and Obstetrics, University Hospital, Ulm. A written and informed consent was obtained from all patients included in this retrospective study. During this period, eight patients, fulfilling the criteria discussed before, were under the care of the Department of Gynecology and Obstetrics. All therapeutic decisions were taken by the interdisciplinary tumor board of the department (after 1999).
RESULTS: In the retrospective analysis of our study group, we found a high percentage of haematogenous metastasis that was always accompanied with a very poor prognosis in malignant CSP patients. Those patients always died within a short period of time. Two of these patients showed, while they underwent initial surgery, no metastatic suspect lesions and underwent R0 resection; both received a radical mastectomy. One patient already showed lung metastasis while undergoing first line surgery, because she initially declined surgery. We therefore speculate that postoperative adjuvant chemotherapy could lead to a favorable outcome in high risk patients, concerning the development of haematogenous metastasis.
Lukas Schwentner; Christian Kurzeder; Rolf Kreienberg; Achim Wöckel
Related Documents :
16246496 - Metaplastic carcinoma of the breast: a retrospective review.
21069366 - Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institut...
8387066 - Primary chemotherapy and radiosurgical breast-conserving treatment for patients with lo...
3127036 - Management of inflammatory carcinoma of the breast with combined modality therapy inclu...
20672316 - High preoperative plasma fibrinogen levels are associated with distant metastases and i...
7413146 - Helium ion charged particle therapy for choroidal melanoma.
Publication Detail:
Type:  Journal Article     Date:  2010-11-11
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  283     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  591-6     Citation Subset:  IM    
Department of Gynecology and Obstetrics, University Hospital Ulm, Prittwitzstraße 43, 89075, Ulm, Germany,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Newcastle approach to the elbow, a cadaveric study.
Next Document:  Maternal early pregnancy body mass index and risk of preterm birth.